TipHub

₹222

▼ -7.01 -3.06%

As of 13 Nov 2026 · delayed

NSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
NSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-11-10

Arvee Laboratories (India) Ltd. (ARVEE)

Volume: 974Avg Vol 1W: 4,793.6Avg Vol 1M: 5,82952W Range:₹129.11₹290.78
NSE BSE arveelabs.com AI Report
Key Ratios
Checked 13h ago
Market Cap₹245 Cr
Current Price₹222
Previous Close₹229.01
High / Low (52w)₹290.78 / ₹129.11
Volume974
Avg Vol (1W)4,793.6
Avg Vol (1M)5,829
Stock P/E37.06
Book Value₹34.52
Dividend Yield0%
ROE17.34%
ROA10.79%
Revenue (TTM)₹32 Cr
Revenue Growth—
Profit Margin10.52%
Total Debt—
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹5.99
P/B6.43
Debt / Equity0.03
50 DMA₹203.41
200 DMA₹171.49
Day change-3.06%
SurveillanceESM · ESM 1
Price Chart
₹222▲ 35.82% · 1Y
₹291₹1343.8L
2025-11-14
2026-11-13

20-day avg volume: 6K shares

Pros
  • Healthy return on equity of 17.3%.
  • Company is almost debt-free.
  • Revenue grew 21% YoY.
Quarterly Results
MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Revenue₹9 Cr₹6 Cr₹7 Cr₹3 Cr₹10 Cr₹11 Cr₹17 Cr₹25 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹2 Cr₹3 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹1 Cr₹2 Cr₹3 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹55 Cr₹46 Cr₹48 Cr₹41 Cr₹63 Cr₹31 Cr₹39 Cr₹32 Cr
EBITDA₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹7 Cr₹2 Cr₹3 Cr₹3 Cr
Net Profit₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹4 Cr₹1 Cr₹2 Cr₹3 Cr
EPS4.114.172.432.343.740.951.952.29
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹37 Cr₹34 Cr₹41 Cr₹39 Cr₹39 Cr₹38 Cr₹38 Cr₹43 Cr
Total Liabilities₹21 Cr₹15 Cr₹20 Cr₹15 Cr₹11 Cr₹9 Cr₹6 Cr₹9 Cr
Equity₹16 Cr₹19 Cr₹21 Cr₹24 Cr₹28 Cr₹29 Cr₹31 Cr₹34 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹3 Cr₹2 Cr₹5 Cr₹4 Cr₹0 Cr₹0 Cr
Investing₹-1 Cr₹0 Cr₹-1 Cr₹-2 Cr₹-1 Cr₹1 Cr
Financing₹5 Cr₹-6 Cr₹-2 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹3 Cr₹2 Cr₹5 Cr₹4 Cr₹0 Cr₹0 Cr
Shareholding
Promoter 73.5% Institutions 0% Public 26.5%
About Arvee Laboratories (India) Ltd.

Basic Materials · Specialty Chemicals

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.

arveelabs.com ↗
Efficiency & Working Capital
ROCE20.3%
Interest Coverage11.6
Dividend Payout—
Debtor Days121 d
Inventory Days106 d
Payable Days74 d
Cash Conversion Cycle153 d
Working Capital Days228 d
Shareholding Details

As of 2026-09-30

Promoter73.5%
FII0%
DII0%
Institutions0%
Public26.5%
Promoter Pledge0%
No. of Shareholders1,947
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters73.5%73.5%73.5%73.5%73.5%73.5%73.5%73.5%73.5%73.5%73.5%73.5%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public26.5%26.5%26.5%26.5%26.5%26.5%26.5%26.5%26.5%26.5%26.5%26.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,3721,2981,4801,4161,6231,5761,5051,5051,8611,6381,5961,947
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Shalin Sudhakarbhai PatelShareholding of Promoter and Promoter Group36.7%40,42,000
Mitaben Bharatbhai ChokshiShareholding of Promoter and Promoter Group24.6%27,08,000
Kavita Shalin ChokshiShareholding of Promoter and Promoter Group12.2%13,40,000
Gitaben Dineshbhai PatelPublic Shareholding10%11,00,000
Deval Pranav PatelPublic Shareholding5.2%5,72,000
Jashbhai PatelPublic Shareholding4.8%5,28,000
Madhuben Jashbhai PatelPublic Shareholding3.7%4,08,000
Khushbuben Shalinbhai PatelShareholding of Promoter and Promoter Group0%2,000
Sudhakar Chhotabhai Patel HufShareholding of Promoter and Promoter Group0%2,000
Shalinbhai Sudhakarbhai Patel HufShareholding of Promoter and Promoter Group0%2,000
Chandrabalaben PatelShareholding of Promoter and Promoter Group0%2,000
Forum Saumil ChokshiShareholding of Promoter and Promoter Group0%2,000
Bharat Rasiklal ChokshiShareholding of Promoter and Promoter Group0%0
Saumil Bharatbhai ChokshiShareholding of Promoter and Promoter Group0%0
Dhaval Sunilbhai ThakkarShareholding of Promoter and Promoter Group0%0
Veer Shalin PatelShareholding of Promoter and Promoter Group0%0
Shalin Bharatbhai ChokshiShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Shalin Sudhakarbhai PatelChairman & Managing Director2020
Shalin Bharat ChokshiWhole-time Director2020
Chandrakala Ashok BhattIndependent Director2020
Vishal Nitin MehtaIndependent Director2020
Amishkumar Maheshkumar ShahIndependent Director2020
Paragbhai Manubhai ShahIndependent Director2020
Neetu JalanIndependent Director2020
SACHIN KANWARLAL KANSALIndependent Director2020
Segments — Geography
RegionRevenueShare
Domestic Sales₹22 Cr70.5%
Export Sales₹9 Cr29.5%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10111111
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-07Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026020306
2026000202
2026020104
Company Information
Incorporated2012
ChairmanShalin Sudhakarbhai Patel
AuditorNirav Patel & Associates
Investor Email[email protected]
🌐 www.arveelabs.com ↗

📍 49/3 B Shyamal Row House, 100 Feet Road Satelitte, Ahmedabad, Gujarat, 380015

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Arrow Greentech LimitedArshiya LimitedAnand Rathi Share & Stock Brokers Ltd.Artemis Medicare Services Ltd.Art Nirman LimitedArunaya Organics LimitedArvindArvind Fashions LimitedArvind port And Infra Ltd.Arvind SmartSpaces Ltd.Aryaman Financial Serv LimitedAsahi India Glass LimitedAll “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search